Tech Company Financing Transactions
Via Nova Therapeutics Funding Round
Via Nova Therapeutics, based in Oakland, secured $20 million from Aditum Bio.
Transaction Overview
Company Name
Announced On
9/9/2021
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance the development of four preclinical antiviral programs in-licensed from Novartis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1111 Bdwy. 1300
Oakland, CA 94607
USA
Oakland, CA 94607
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections for which current treatments are lacking or inadequate.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Don Ganem
Browse more venture capital transactions:
Prev: 9/9/2021: InBrace venture capital transaction
Next: 9/9/2021: Alamar Biosciences venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs